Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis

Area of Science:

• Pediatric Rheumatology
• Immunology
• Autoantibody Research

Background:

• Juvenile Idiopathic Arthritis (JIA) is a complex autoimmune condition affecting children.
• Early diagnosis and treatment are crucial for managing JIA and preventing long-term joint damage.
• The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in pediatric JIA requires further elucidation.

Purpose of the Study:

• To determine the prevalence of anti-CCP antibodies in children diagnosed with JIA.
• To investigate the clinical significance and diagnostic value of anti-CCP antibodies in JIA.
• To explore correlations between anti-CCP antibodies and patient age, sex, and disease activity.

Main Methods:

• A case-control study involving 50 JIA patients and 40 age/sex-matched controls.
• Clinical assessment, laboratory investigations, and X-rays were performed on JIA patients.
• Anti-CCP IgG antibodies were quantified using the AxSYM Anti-CCP IgG MEIA assay.

Main Results:

• Anti-CCP antibodies were detected in JIA patients, notably in those with RF-positive polyarticular onset.
• Significant correlations were observed between anti-CCP positivity and bone erosions, joint damage severity, and ESR levels.
• These findings highlight the association of anti-CCP antibodies with disease burden in JIA.

Conclusions:

• Anti-CCP antibodies serve as a valuable biomarker in the polyarticular subtype of JIA.
• Detection of anti-CCP antibodies can guide early and potentially aggressive therapeutic interventions.
• This research supports the utility of anti-CCP testing for improved JIA management.